Chief Technology Officer Yang Zheng


Graduated in 2002 from China Pharmaceutical University with a Master's degree in Science. Previously worked in research and development at Guangxi Drug Research Institute, China Pharmaceutical University, Shanghai Hechen Pharmaceutical, Eisai (China) Pharmaceutical Co., Ltd., and Nanjing Congyi Pharmaceutical Consulting Co., Ltd. Has over 10 years of experience in drug research and development registration, holding 4 authorized invention patents and 7 utility model patents, and has published 5 academic papers. Led and participated in preclinical research of Edaravone new drugs, established analysis methods for the degradation products of Ethylphenidate Hydrochloride, developed testing reagents for drug-induced hearing loss, and developed film-forming agents for wound protection, among other pharmaceutical and medical device product development work; obtained import drug registration certificates for 8 patented drugs, 6 certificates for category 4 new drugs, 3 clinical research approvals, 2 class II sterile medical device registration certificates, 2 class I disinfectant product safety evaluation filings, and 3 class I non-sterile medical device product filing certificates. Currently one of the founders and actual controllers of Haizhi Company, responsible for the overall work of the production quality management system for medical devices and disinfectant products.

Chief Technology Officer Yang Zheng